Obakan Yerlikaya, P. Et Al. 2022. Gemcitabine in combination with epibrassinolide enhanced the apoptotic response in an ER stress-dependent manner and reduced the epithelial-mesenchymal transition in pancreatic cancer cells. Turkish Journal of Biology , vol.46, no.6 .

Obakan Yerlikaya, P., Mehdizadehtapeh, L., Rencüzoğullari, Ö., Kuryayeva, F., Çevikli, S. S., Özağar, Ş., ... Odabaş, S. P.(2022). Gemcitabine in combination with epibrassinolide enhanced the apoptotic response in an ER stress-dependent manner and reduced the epithelial-mesenchymal transition in pancreatic cancer cells. Turkish Journal of Biology , vol.46, no.6.

Obakan Yerlikaya, Pınar Et Al. "Gemcitabine in combination with epibrassinolide enhanced the apoptotic response in an ER stress-dependent manner and reduced the epithelial-mesenchymal transition in pancreatic cancer cells," Turkish Journal of Biology , vol.46, no.6, 2022

Obakan Yerlikaya, Pınar O. Et Al. "Gemcitabine in combination with epibrassinolide enhanced the apoptotic response in an ER stress-dependent manner and reduced the epithelial-mesenchymal transition in pancreatic cancer cells." Turkish Journal of Biology , vol.46, no.6, 2022

Obakan Yerlikaya, P. Et Al. (2022) . "Gemcitabine in combination with epibrassinolide enhanced the apoptotic response in an ER stress-dependent manner and reduced the epithelial-mesenchymal transition in pancreatic cancer cells." Turkish Journal of Biology , vol.46, no.6.

@article{article, author={Pınar Obakan Yerlikaya Et Al. }, title={Gemcitabine in combination with epibrassinolide enhanced the apoptotic response in an ER stress-dependent manner and reduced the epithelial-mesenchymal transition in pancreatic cancer cells}, journal={Turkish Journal of Biology}, year=2022}